Schedule 13D ownership disclosure

NOVABRIDGE BIOSCIENCES

Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) · CUSIP: 44975P103

Event date: 2025-01-29

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • CBC Investment I-Mab LimitedReported CIK 0001845246

    Shares: 11,784,164.00 · Class: 6.3%

  • IBC Investment Seven Limited

    Shares: 3,641,554.00 · Class: 1.9%

  • CBC SPVII LIMITED

    Shares: 5,574,560.00 · Class: 3.0%

  • C-Bridge II Investment Ten Limited

    Shares: 2,369,546.00 · Class: 1.3%

  • Everest Medicines Limited

    Shares: 6,078,571.00 · Class: 3.2%

  • Nova Aqua Limited

    Shares: 4,122,768.00 · Class: 2.2%

  • C-Bridge Healthcare Fund II, L.P.

    Shares: 14,153,710.00 · Class: 7.6%

  • C-Bridge Healthcare Fund GP II, L.P.

    Shares: 14,153,710.00 · Class: 7.6%

  • C-Bridge Capital GP, Ltd.

    Shares: 23,369,824.00 · Class: 12.5%

  • I-Bridge Healthcare Fund, L.P.

    Shares: 9,216,114.00 · Class: 4.9%

  • I-Bridge Healthcare GP, L.P.

    Shares: 9,216,114.00 · Class: 4.9%

  • I-Bridge Capital GP, Ltd.

    Shares: 9,216,114.00 · Class: 4.9%

  • Wei Fu

    Shares: 33,571,163.00 · Class: 17.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-003167
Form type
SCHEDULE 13D
Filer
CBC Investment I-Mab Ltd
CIK
CIK 1845246
Filed
Feb 05, 2025
Reporting period
Jan 29, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub